|A service of the U.S. National Library of Medicine®|
What advances are being made in DNA sequencing?
Determining the order of DNA building blocks (nucleotides) in an individual’s genetic code, called DNA sequencing, has advanced the study of genetics and is one method used to test for genetic disorders.
New technologies that allow rapid sequencing of large amounts of DNA are being developed. The original sequencing technology, called Sanger sequencing (named after the scientist who developed it, Frederick Sanger), was a breakthrough that helped scientists determine the human genetic code, but it is time-consuming and expensive. The Sanger method has been automated to make it faster and is still used in laboratories today to sequence short pieces of DNA, but it would take years to sequence all of a person’s DNA (known as the person’s genome). Several technologies have been developed more recently, called next-generation sequencing (or next-gen sequencing), that have sped up the process (taking only days to weeks to sequence a human genome) while reducing the cost.
With next-generation sequencing, it is now feasible to sequence large amounts of DNA, for instance all the pieces of an individual’s DNA that provide instructions for making proteins. These pieces, called exons, are thought to make up 1 percent of a person’s genome. Together, all the exons in a genome are known as the exome, and the method of sequencing them is known as whole exome sequencing. This method allows variations in the protein-coding region of any gene to be identified, rather than a select few genes. Because most known mutations that cause disease occur in exons, whole exome sequencing is thought to be an efficient method to identify possible disease-causing mutations.
However, researchers have found that DNA variations outside the exons can affect gene activity and protein production and lead to genetic disorders–variations that whole exome sequencing would miss. Another method, called whole genome sequencing, determines the order of all the nucleotides in an individual’s DNA and can determine variations in any part of the genome.
While many more genetic changes can be identified with whole exome and whole genome sequencing than with select gene sequencing, the significance of much of this information is unknown. Because not all genetic changes affect health, it is difficult to know whether identified variants are involved in the condition of interest. Sometimes, an identified variant is associated with a different genetic disorder that has not yet been diagnosed (these are called incidental or secondary findings).
In addition to being used in the clinic, whole exome and whole genome sequencing are valuable methods for researchers. Continued study of exome and genome sequences can help determine whether new genetic variations are associated with health conditions, which will aid disease diagnosis in the future.
For more information about DNA sequencing technologies and their use:
Genetics Home Reference discusses whether all genetic changes affect health and development.
A scientist at the Genome Institute at the University of Washington describes the different sequencing
An illustration of the decline in the cost of DNA
The American College of Medical Genetics and Genomics (ACMG) has laid out their policies regarding whole exome and whole genome
The PHG Foundation (UK) provides an overview of whole genome
The Mount Sinai School of Medicine Genomics Core Facility describes the techniques used in whole exome
The Smithsonian National Museum of Natural History’s exhibit ‘Genome: Unlocking Life’s Code’ discusses the
Next: Precision Medicine